In fact, C3G is a rare chronic kidney disease mediated by a dysregulation of the AP, which is due to uncontrolled C3 and/or C5 convertase activation, leading to C3 deposits and intra-glomerular inflammation (39). This evidence concerns the gene C3 and complement 3 glomerulopathy.